Slaughter and May advised Viatris in connection with the divestiture of its OTC business to Cooper Consumer Health

Slaughter and May advised Viatris Inc., the US pharmaceuticals group, in connection with its divestiture of its Over-the-Counter (“OTC”) drugs business to Cooper Consumer Health, a European manufacturer and distributor of OTC products (Viatris’s SEC filing dated 1 October 2023). The transaction completed on 3 July 2024.